These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 1387704

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Ondansetron reduces chemotherapy induced nausea and vomiting refractory to standard antiemetics.
    Mitchell PL, Evans BD, Allan SG, Forgeson GV, Mak D, Neave L, Humm G, Langley G, Dickson D, Harvey VJ.
    N Z Med J; 1992 Mar 11; 105(929):73-5. PubMed ID: 1532054
    [Abstract] [Full Text] [Related]

  • 7. Patterns of nausea and vomiting in children: nursing assessment and intervention.
    Hockenberry-Eaton M, Benner A.
    Oncol Nurs Forum; 1990 Mar 11; 17(4):575-84. PubMed ID: 2204886
    [Abstract] [Full Text] [Related]

  • 8. [The management of vomiting and nausea with zofran during the chemotherapy of malignant tumors].
    Seliuzhitskiĭ IV, Eliseev SN, Ivanov AI.
    Voen Med Zh; 1994 Oct 11; (10):34-6. PubMed ID: 7831851
    [No Abstract] [Full Text] [Related]

  • 9. Ondansetron in the treatment of nausea and vomiting. Introduction.
    Marschner N.
    Anticancer Drugs; 1993 Dec 11; 4 Suppl 2():3-7. PubMed ID: 8136513
    [No Abstract] [Full Text] [Related]

  • 10. Ondansetron, an antagonist of 5-HT3 receptors, in the treatment of antineoplastic drug-induced nausea and vomiting in children.
    Matera MG, Di Tullio M, Lucarelli C, Casale F, Calabria C, Lampa E, Indolfi P, Rossi F.
    J Med; 1993 Dec 11; 24(2-3):161-70. PubMed ID: 7691978
    [Abstract] [Full Text] [Related]

  • 11. Practical points in the use of ondansetron.
    Litwack K.
    J Post Anesth Nurs; 1994 Jun 11; 9(3):162-3. PubMed ID: 7799235
    [Abstract] [Full Text] [Related]

  • 12. Ondansetron and cisplatin-induced nausea and vomiting.
    Hait WN.
    N Engl J Med; 1990 Nov 22; 323(21):1485-6. PubMed ID: 2146502
    [No Abstract] [Full Text] [Related]

  • 13. Zofran: first of a new class of antiemetics.
    Wilson BA.
    Medsurg Nurs; 1994 Jun 22; 3(3):218-9. PubMed ID: 8055040
    [No Abstract] [Full Text] [Related]

  • 14. Odansetron.
    Betcher DL, Burnham N.
    J Pediatr Oncol Nurs; 1991 Oct 22; 8(4):183-5. PubMed ID: 1834086
    [No Abstract] [Full Text] [Related]

  • 15. Ondansetron: a new entity in emesis control.
    Graves T.
    DICP; 1990 Nov 22; 24(11 Suppl):S51-4. PubMed ID: 2148659
    [Abstract] [Full Text] [Related]

  • 16. [Chemically induced nausea and vomiting].
    Farnault G.
    Soins; 1999 May 22; (635):21-2. PubMed ID: 10595215
    [No Abstract] [Full Text] [Related]

  • 17. [Ondansetron--a 5HT 3 receptor antagonist for the treatment of nausea and vomiting induced by cytostatics and radiotherapy].
    Herrstedt J, Ersbøll J, Dombernowsky P.
    Ugeskr Laeger; 1991 Apr 29; 153(18):1292-5. PubMed ID: 1827555
    [No Abstract] [Full Text] [Related]

  • 18. Managing chemotherapy-related nausea and vomiting: the state of the art.
    Wickham R.
    Oncol Nurs Forum; 1989 Apr 29; 16(4):563-74. PubMed ID: 2666957
    [Abstract] [Full Text] [Related]

  • 19. Emesis as a complication of cancer chemotherapy: pathophysiology, importance, and treatment.
    Graves T.
    Pharmacotherapy; 1992 Apr 29; 12(4):337-45. PubMed ID: 1387707
    [Abstract] [Full Text] [Related]

  • 20. [The antiemetic effect and clinical evaluation of metoclopramide alone and combined with betamethasone in children with malignant tumor].
    Hatae Y, Takeda T, Nakadate H, Hatayama Y, Kishino T, Ogawa Y.
    Gan To Kagaku Ryoho; 1989 Nov 29; 16(11):3639-42. PubMed ID: 2817913
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.